Howard Perell
Ophthalmology · Glen Burnie, MDNPI 1548258486
Payments from drug & device makers
Across 196 payments — averaging $170.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerie Pharmaceuticals, Inc.$18K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$10K
- AbbVie$1K
- Bausch & Lomb Americas Inc.$1K
- Sun Pharmaceutical Industries Inc.$379
- Alcon$372
- plus $2K from 11 others
What the payments were for
- Consulting fees$2,5908%
- Speaking & faculty fees$22,09466%
- Travel & lodging$1,9246%
- Food & beverage$6,54520%
- Education$1020%
- Gifts$640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | 32 | $17,803 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 36 | $10,368 |
| AbbVie(2 entities) | 65 | $1,475 |
| Bausch & Lomb Americas Inc. | 20 | $1,290 |
| Sun Pharmaceutical Industries Inc. | 10 | $379 |
| Alcon | 8 | $372 |
| Kala Pharmaceuticals, Inc. | 8 | $360 |
| Ivantis, Inc | 3 | $301 |
| Eyevance Pharmaceuticals LLC | 3 | $287 |
| Thea Pharma Inc. | 3 | $249 |
| Sight Sciences, Inc. | 2 | $131 |
| Tarsus Pharmaceuticals, Inc. | 1 | $126 |
| Amgen | 1 | $100 |
| Omeros Corporation | 1 | $28 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Akorn Operating Company LLC | 1 | $17 |
| Akorn, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rocklatan$17,247
- Rhopressa$17,247
- VYZULTA$10,005
- MIEBO$486
- XIIDRA$486
- Hydrus$279
- INVELTYS$240
- LUMIGAN$236
- COMBIGAN$236
- CEQUA$226
- Tobradex ST$223
- enVista MX60 IOL$149
- STELLARIS ELITE$149
- XDEMVY$126
- OMNI$123
- XEN GLAUCOMA TREATMENT SYSTEM$115
- XEN$109
- DOCTORS ALLERGY FORMULA$108
How this compares
$33,320 in reported general payments places this provider in the 85th percentile of 493 ophthalmology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyzultaLatanoprostene Bunod | 27 | $19,169 |
| LumiganBimatoprost | 20 | $11,644 |
| RocklatanNetarsudil Mesylat/Latanoprost | 11 | $11,526 |
| Travoprost | 26 | $9,591 |
| RhopressaNetarsudil Mesylate | 19 | $8,282 |
| Brimonidine Tartrate | 23 | $6,713 |
| Brinzolamide | 11 | $3,982 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 14 | $3,432 |
| Timolol Maleate | 15 | $1,733 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 54 | $1,423 |
| Latanoprost | 81 | $1,067 |
| Dorzolamide Hcl | 21 | $336 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $17,803 | $19,80830 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $1,290 | $19,16927 claims |
| AbbVieLumigan | $1,475 | $11,64420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 493 ophthalmology providers in Maryland.
Other ophthalmology in Glen Burnie
- Allen HuHagerstown$47.9M
- David WarrowHagerstown$10M
- Daniel FinkelsteinBaltimore$6.9M
- Eric SuanBaltimore$6.9M
- Peter CampochiaroBaltimore$5.4M
- Neil BresslerBaltimore$3.6M
- Alfred SommerBaltimore$2.9M
- Richard AdlerBaltimore$2.7M
- John ThompsonBaltimore$1.8M
- Peter McDonnellBaltimore$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.